* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Sunday, June 29, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Susquehanna Raises Penn Entertainment Inc. (PENN) Price Target. – Yahoo Finance

    Susquehanna Raises Price Target for Penn Entertainment Inc. (PENN)

    George Lopez is coming to Spokane – KXLY.com

    George Lopez is coming to Spokane – KXLY.com

    Netflix unveils Dallas immersive venue for fans of hit shows like ‘Squid Game,’ ‘Stranger Things’ – Houston Chronicle

    Step Inside Netflix’s New Dallas Immersive Experience Featuring Hits Like ‘Squid Game’ and ‘Stranger Things

    ‘Puttin’ on the Ritz’: Civic Players bring ‘Young Frankenstein’ to life – Yahoo

    Civic Players Deliver a Hilarious and Unforgettable Performance of ‘Young Frankenstein

    ‘Wheel of Fortune’: Amputee Wins $60,000 After Breaking Incredible ‘Curse’ – Hastings Tribune

    Wheel of Fortune’ Amputee Breaks Incredible ‘Curse’ to Win $60,000!

    North Star Sports & Entertainment Network: Coming soon – KTTC News

    North Star Sports & Entertainment Network: Coming soon – KTTC News

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Naples restaurant owner prepares for hurricane season with new flood technology – Fox4Now.com

    Naples restaurant owner prepares for hurricane season with new flood technology – Fox4Now.com

    Emerging Memory and Storage Technology Market Analysis Report 2025-2034 | AI and HPC Boom Fuels Surging Demand for Fast, Low-Power Memory Devices – Yahoo Finance

    How AI and HPC Are Driving Explosive Growth in Fast, Low-Power Memory Technologies Through 2034

    Ostin Technology (OST): Volatility’s Warning or Contrarian Opportunity? – AInvest

    Ostin Technology (OST): Navigating Market Volatility – Red Flag or Hidden Opportunity?

    St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

    St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

    Wayve Expands Engineering Leadership to Power Next-Gen Autonomous Driving Technology – Silicon Canals

    Wayve Boosts Engineering Leadership to Accelerate Next-Gen Autonomous Driving Innovation

    Frontdoor Announces Tech Expert Dr. Bala Ganesh as Chief Technology Officer – Business Wire

    Frontdoor Appoints Tech Visionary Dr. Bala Ganesh as New Chief Technology Officer

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Susquehanna Raises Penn Entertainment Inc. (PENN) Price Target. – Yahoo Finance

    Susquehanna Raises Price Target for Penn Entertainment Inc. (PENN)

    George Lopez is coming to Spokane – KXLY.com

    George Lopez is coming to Spokane – KXLY.com

    Netflix unveils Dallas immersive venue for fans of hit shows like ‘Squid Game,’ ‘Stranger Things’ – Houston Chronicle

    Step Inside Netflix’s New Dallas Immersive Experience Featuring Hits Like ‘Squid Game’ and ‘Stranger Things

    ‘Puttin’ on the Ritz’: Civic Players bring ‘Young Frankenstein’ to life – Yahoo

    Civic Players Deliver a Hilarious and Unforgettable Performance of ‘Young Frankenstein

    ‘Wheel of Fortune’: Amputee Wins $60,000 After Breaking Incredible ‘Curse’ – Hastings Tribune

    Wheel of Fortune’ Amputee Breaks Incredible ‘Curse’ to Win $60,000!

    North Star Sports & Entertainment Network: Coming soon – KTTC News

    North Star Sports & Entertainment Network: Coming soon – KTTC News

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Naples restaurant owner prepares for hurricane season with new flood technology – Fox4Now.com

    Naples restaurant owner prepares for hurricane season with new flood technology – Fox4Now.com

    Emerging Memory and Storage Technology Market Analysis Report 2025-2034 | AI and HPC Boom Fuels Surging Demand for Fast, Low-Power Memory Devices – Yahoo Finance

    How AI and HPC Are Driving Explosive Growth in Fast, Low-Power Memory Technologies Through 2034

    Ostin Technology (OST): Volatility’s Warning or Contrarian Opportunity? – AInvest

    Ostin Technology (OST): Navigating Market Volatility – Red Flag or Hidden Opportunity?

    St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

    St. Francis Medical Center brings advanced robotic surgery technology to Northeast Louisiana – KNOE

    Wayve Expands Engineering Leadership to Power Next-Gen Autonomous Driving Technology – Silicon Canals

    Wayve Boosts Engineering Leadership to Accelerate Next-Gen Autonomous Driving Innovation

    Frontdoor Announces Tech Expert Dr. Bala Ganesh as Chief Technology Officer – Business Wire

    Frontdoor Appoints Tech Visionary Dr. Bala Ganesh as New Chief Technology Officer

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Ozanimod Controls MS Disease Activity Regardless of Age

March 4, 2024
in Health
Ozanimod Controls MS Disease Activity Regardless of Age
Share on FacebookShare on Twitter

WEST PALM BEACH, Fla. — Clinical and radiologic measures of disease activity remained stable or improved for relapsing multiple sclerosis (RMS) patients in all age groups over 7 to 8 years of continuous treatment with ozanimod (Zeposia).

“Regardless of age category, the adjusted annualized relapse rate was below 0.2 in the phase III parent trials and remained low in the DAYBREAK open-label extension in patients treated with continuous ozanimod,” said Jeffrey Cohen, MD, of the Cleveland Clinic in Ohio, in a poster presentation at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) forum.

A total of 2,257 RMS patients in the parent SUNBEAM and RADIANCE trials participated in the open-label DAYBREAK extension study. By age category, the number of patients treated continuously with 0.92 mg ozanimod from the start of the phase III trials included 118 people ages 25 or younger, 268 people ages 26 to 35, 313 people ages 36 to 50, and 62 people ages 50 and older.

Patients continually taking ozanimod, an oral sphingosine 1-phosphate (S1P) receptor 1 and 5 modulator, had consistently lower rates of relapse and almost always had numerically lower rates of relapse than those who originally received interferon beta-1a before being switched to ozanimod, Cohen said.

“We also noted that even the patients who started the trial on interferon, when they switched to ozanimod in the open-label extension, they basically caught up to the people who were on ozanimod the entire length of the phase III trials and the extension,” he told MedPage Today.

There were similar relationships on age for the number of gadolinium-enhancing lesions, which averaged 0.6 per scan throughout the open-label extension, Cohen added. The number of new or enlarging T2 lesions per scan was reduced as patients got older, he said.

“This is something that has been observed in relapsing multiple sclerosis over time,” Cohen noted. A decline in these lesions may be part of declining immune activity as people age, he suggested. Long-term treatment also may interrupt the cascade of molecular inflammatory events that can cause nerve injury, he noted.

Ozanimod was approved to treat RMS in 2020 based on data from the pivotal SUNBEAM and RADIANCE studies, which showed lower relapse rates with ozanimod compared with interferon beta-1a. Patients who completed SUNBEAM and RADIANCE were eligible to enroll in the open-label extension of ozanimod 0.92 mg.

Cohen explained that while the relapses and appearance of new lesions remained low overall in the extension study, the team wanted to determine whether those rates diminished with age.

The findings should be reassuring to clinicians who are treating older patients with ozanimod for long durations, noted Patrick Vermersch, MD, PhD, of University Hospital Lille in France, who wasn’t involved with the study.

“When you treat long-term with these immune-modulating agents, there is always a concern that the risk of infections can occur, and the risk would be greater in an older patient,” Vermersch told MedPage Today. “We did not see this occur in patients in the DAYBREAK study.”

In a companion study presented at the meeting, Cohen and colleagues reported that the final analysis of the DAYBREAK extension study showed that treatment with 0.92 mg ozanimod controlled disease activity for longer than previously reported — a mean of 60.9 months, with some patients having been on treatment for 117.2 months (i.e., nearly 10 years).

“Ozanimod was generally well tolerated, with 78.2% of participants completing the study,” Cohen said. “Ozanimod demonstrated sustained efficacy with a low annualized relapse rate of 0.098, low numbers of new or enlarging T2 lesions of an average of less than 1 new or enlarging lesion per scan at 60 months, and mean number of gadolinium-enhancing lesions on brain MRI of an average of about 0.24 lesions per scan at 60 months.”

The safety findings were consistent with phase III trials and the established safety profile of ozanimod, Cohen noted.

“While we rarely would start a patient on interferons or glatiramer acetate these days but rather on disease-modifying agents, it is still good that we have this data to show there is an advantage to the use of these newer agents such as ozanimod,” he said.

author['full_name']

Ed Susman is a freelance medical writer based in Fort Pierce, Florida, USA.

Disclosures

The ozanimod studies were sponsored by Bristol Myers Squibb.

Cohen disclosed financial relationships with Astoria, Bristol Myers Squibb, Convelo, EMD Serono, Find Therapeutics, INmune, and Sandoz.

Vermersch disclosed relationships with Bristol-Myers Squibb, Novartis, Merck, EMD Serono, Biogen, and Sanofi.

Primary Source

Americas Committee for Treatment and Research in Multiple Sclerosis Forum

Source Reference: Cree BAC, et al “Long-term efficacy of the sphingosine 1-phosphate receptor modulator ozanimod by age category in patients with relapsing multiple sclerosis: final results from two phase 3 trials and an open-label extension trial” ACTRIMS Forum 2024; poster P091.

Secondary Source

Americas Committee for Treatment and Research in Multiple Sclerosis Forum

Source Reference: Selmaj KW, et al “Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: final analysis of the DAYBREAK open-label extension study” ACTRIMS Forum 2024; poster P090.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/meetingcoverage/actrims/108994

Tags: ControlshealthOzanimod
Previous Post

“I Have the Unfortunate Genetics That I Am Bald”: What We Heard This Week

Next Post

School Shootings in U.S. Reach Highest Recorded Levels

Naples restaurant owner prepares for hurricane season with new flood technology – Fox4Now.com

Naples restaurant owner prepares for hurricane season with new flood technology – Fox4Now.com

June 29, 2025
Fireworks sales support Folsom youth sports: ‘This is our biggest fundraiser’ – Sacramento Bee

Fireworks Sales Ignite Support for Folsom Youth Sports: “This Is Our Biggest Fundraiser

June 29, 2025
Murder, she measured: The impressive science behind Agatha Christie’s poisons – Big Think

Deadly Secrets Unveiled: The Fascinating Science Behind Agatha Christie’s Poisons

June 28, 2025
Science and social norms – Golf Course Management magazine

How Science is Revolutionizing Social Norms in Golf Course Management

June 28, 2025
Study Links Skipping Breakfast to Poor Diet and Lifestyle Habits in Teens – Olive Oil Times

Study Links Skipping Breakfast to Poor Diet and Lifestyle Habits in Teens – Olive Oil Times

June 28, 2025
What Worries the World – June 2025 – Ipsos

Top Global Concerns Shaping June 2025

June 28, 2025
Small business owners aren’t jumping for joy about the US economy – but they still aren’t jumping ship – The Guardian

Small Business Owners Hold Firm Amid Ongoing Uncertainty About the US Economy

June 28, 2025
U.S. uninsured rates could resurge if Trump’s budget bill passes – NPR

U.S. Uninsured Rates Could Surge if Trump’s Budget Bill Becomes Law

June 28, 2025
Emerging Memory and Storage Technology Market Analysis Report 2025-2034 | AI and HPC Boom Fuels Surging Demand for Fast, Low-Power Memory Devices – Yahoo Finance

How AI and HPC Are Driving Explosive Growth in Fast, Low-Power Memory Technologies Through 2034

June 28, 2025
Axios Event: Media execs are betting big on women’s sports – Axios

Axios Event: Media execs are betting big on women’s sports – Axios

June 28, 2025

Categories

Archives

June 2025
MTWTFSS
 1
2345678
9101112131415
16171819202122
23242526272829
30 
« May    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (699)
  • Economy (722)
  • Entertainment (21,613)
  • General (15,611)
  • Health (9,761)
  • Lifestyle (727)
  • News (22,149)
  • People (723)
  • Politics (728)
  • Science (15,939)
  • Sports (21,219)
  • Technology (15,707)
  • World (702)

Recent News

Naples restaurant owner prepares for hurricane season with new flood technology – Fox4Now.com

Naples restaurant owner prepares for hurricane season with new flood technology – Fox4Now.com

June 29, 2025
Fireworks sales support Folsom youth sports: ‘This is our biggest fundraiser’ – Sacramento Bee

Fireworks Sales Ignite Support for Folsom Youth Sports: “This Is Our Biggest Fundraiser

June 29, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version